Dexamethasone Injection 4 MG/ML

Categories:Glucocorticoid, Hormonal Therapy Product, Steroids SKU: 00001-50

Dexamethasone Injection 4 MG/ML

Download as PDF

Enquire Now

Add to Compare

Description
Reviews (0)

Description

PRODUCT DESCRIPTION:

Dexamethasone is a highly potent synthetic corticosteroid with anti-inflammatory, immunosuppressive, and anti-allergic properties.

It is widely used in the management of acute and chronic inflammatory conditions, endocrine disorders, cerebral edema, allergic reactions, and as adjunct therapy in oncology and COVID-19 care.

PHARMET’s Dexamethasone Injection 4 MG/ML is a fast-acting, parenteral formulation, ensuring immediate clinical effect in critical care, emergency medicine, and hospital settings.

Manufactured in WHO-GMP certified facilities, the product guarantees quality, stability, and global regulatory compliance.

Formulation & Presentation:

Dosage Form: Injectable Aqueous Solution/Suspension
Presentation: Sterile, single-use ampoule or vial (customizable as per market demand)
Available Strengths: 4 MG/ML Vial/Ampoule
Route of Administration: Intramuscular (IM), or as per clinical indication and severity (As per physician’s discretion or decision)

Therapeutic Indications:

Acute allergic reactions and anaphylaxis (as adjunct therapy)
Cerebral edema associated with brain tumors or trauma
Adrenal insufficiency and Addison’s disease (as part of steroid replacement)
Severe inflammatory or autoimmune conditions such as rheumatoid arthritis, SLE, and ulcerative colitis
Oncology (as antiemetic or for reducing tumor-associated inflammation)
COVID-19 and ARDS management in hospital settings (as per evolving guidelines)

Side Effects:

COMMON:
- Transient pain at injection site
- Hyperglycemia
- Insomnia or mood changes
- Increased appetite or weight gain
SERIOUS (RARE):
- Adrenal suppression with prolonged use
- Gastrointestinal bleeding or ulcers
- Osteoporosis
- Risk of secondary infections due to immunosuppression
PRECAUTIONS:
- Avoid abrupt discontinuation after prolonged therapy—requires tapering
- Monitor blood glucose, electrolytes, and bone mineral density in long-term use
- Caution in patients with peptic ulcer, hypertension, or psychiatric history
- Should be used under medical supervision with dose adjustment in pediatric and geriatric populations

Reviews

There are no reviews yet.

Be the first to review “Dexamethasone Injection 4 MG/ML” Cancel reply

TECHNICAL INFORMATION

Product Specifications:

HSN Code: To be assigned per international classification standards & import jurisdiction
Weight: Approx. 40g per Carton (With Packaging)
Dimensions: (15x1x8 CMS)
Shelf Life (Subject To Country Specific Guidelines): 24 to 36 months under recommended storage conditions from date of manufacture or as per label specifications. Cold chain not mandatory.
Storage: Not an oil-based injectable solution & may not require cold-chain logistics (if specified by packaging). Protect from moisture and direct sunlight. The solution should be used strictly as per label guidelines.

Regulatory Status & Supply Information:

Regulatory Status: WHO-GMP Complaint Manufacturing. Further certifications available on request
Exports Ready Dossiers: Dossier Available (CTD/eCTD formats)
Stability: Compliant
MOQ: Negotiable. Based on market & registration status
Export Options: Available for private label, institutional supply, or branded export

Who Should Source This Product?

Dexamethasone Injection 4 MG/ML is suitable for tertiary care hospitals, emergency departments, oncology units, critical care centers, government tenders, and NGOs involved in acute and pandemic response programs.
It is highly relevant for procurement in Africa, Southeast Asia, LATAM, and Eastern Europe, where corticosteroids are frontline agents in a broad spectrum of clinical protocols.

Why Source from PHARMET?